Answers are grounded in this paper and cite their sources.
mouse model of achromatopsia. These novel rAAV vectors expand the clinical applicability of gene therapy for blinding human retinal dystrophies.
No takes yet. Share an insight, caveat, or question.
Pavlou et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: